title: Making a little go a long way...
abstract: In this issue of Blood, Popat et al report the results of a clinical trial designed to test the safety and feasibility of a novel strategy, enforced fucosylation, intended to improve engraftment after donor unrelated cord blood (UCB) transplantation in adults. The data show that the strategy is safe, and that engraftment of platelets and neutrophils is faster in recipients of the modified cord blood (CB) unit when compared with historical controls
authors.affiliation: CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER.
authors.forename: Stella M
authors.initials: SM
authors.lastname: Davies
mesh_terms: D001792:Blood Platelets / Q000166:cytology*; D005260:Female; D005312:Fetal Blood / Q000166:cytology*; D005643:Fucose / Q000378:metabolism*; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D008297:Male; D009504:Neutrophils / Q000637:transplantation*
chemical_list: D005643:Fucose